SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

14 May 2022 Evaluate
The sales surged to Rs. 1289.70 millions, up 32.76% for the March 2022 quarter as against Rs. 971.47 millions during the corresponding quarter previous year.Net Profit for the quarter ended March 2022 zoomed to 894.98% from Rs. 8.97 millions to Rs. 89.25  millions.OP of the company witnessed a marginal growth to 148.99 millions from 56.24 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1289.70 971.47 32.76 4866.46 4319.60 12.66 4866.46 4319.60 12.66
Other Income 10.29 15.60 -34.04 51.97 105.38 -50.68 51.97 105.38 -50.68
PBIDT 148.99 56.24 164.92 520.43 551.22 -5.59 520.43 551.22 -5.59
Interest -1.77 1.51 -217.22 9.61 14.94 -35.68 9.61 14.94 -35.68
PBDT 150.76 54.73 175.46 510.82 536.28 -4.75 510.82 536.28 -4.75
Depreciation 30.07 38.12 -21.12 119.60 150.76 -20.67 119.60 150.76 -20.67
PBT 120.69 16.61 626.61 391.22 385.52 1.48 391.22 385.52 1.48
TAX 31.44 7.64 311.52 85.61 101.15 -15.36 85.61 101.15 -15.36
Deferred Tax -4.56 -0.31 1370.97 -9.95 6.50 -253.08 -9.95 6.50 -253.08
PAT 89.25 8.97 894.98 305.61 284.37 7.47 305.61 284.37 7.47
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 11.55 5.79 99.55 10.69 12.76 -16.20 10.69 12.76 -16.20

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×